Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

To blow one's trumpet - a musical composition that fits the mould. A case report of Purpureocillium lilacinum causing hypersensitivity pneumonitis in a tenor horn player.

Davidson J, McErlane J, Jboor KA, Barratt SL, Jeyabalan A, Medford ARL, Borman AM, Adamali H.

QJM. 2019 Jan 15. doi: 10.1093/qjmed/hcz020. [Epub ahead of print] No abstract available.

PMID:
30649525
2.

Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs.

Barratt SL, Morales M, Spiers T, Al Jboor K, Lamb H, Mulholland S, Edwards A, Gunary R, Meek P, Jordan N, Sharp C, Kendall C, Adamali HI.

BMJ Open Respir Res. 2018 Dec 19;5(1):e000360. doi: 10.1136/bmjresp-2018-000360. eCollection 2018.

3.

South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).

Barratt SL, Mulholland S, Al Jbour K, Steer H, Gutsche M, Foley N, Srivastava R, Sharp C, Adamali HI.

Front Pharmacol. 2018 Dec 17;9:1480. doi: 10.3389/fphar.2018.01480. eCollection 2018.

4.

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone.

Richeldi L, Fletcher S, Adamali H, Chaudhuri N, Wiebe S, Wind S, Hohl K, Baker A, Schlenker-Herceg R, Stowasser S, Maher TM.

Eur Respir J. 2019 Jan 10;53(1). pii: 1801060. doi: 10.1183/13993003.01060-2018. Print 2019 Jan.

PMID:
30442716
5.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA.

Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.

6.

Visual analogue scales for interstitial lung disease: a prospective validation study.

Yates H, Adamali HI, Maskell N, Barratt S, Sharp C.

QJM. 2018 May 16. doi: 10.1093/qjmed/hcy102. [Epub ahead of print]

PMID:
29788503
7.

Pleuroparenchymal sarcoidosis - A recognised but rare manifestation of disease.

Walker S, Adamali H, Bhatt N, Maskell N, Barratt SL.

Respir Med Case Rep. 2018 Feb 3;23:110-114. doi: 10.1016/j.rmcr.2018.01.007. eCollection 2018.

8.

Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD).

Barratt SL, Shaw J, Jones R, Bibby A, Adamali H, Mustfa N, Cliff I, Stone H, Chaudhuri N.

Respir Med. 2018 Feb;135:51-56. doi: 10.1016/j.rmed.2017.12.015. Epub 2018 Jan 8.

PMID:
29414453
9.

An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer.

Reynolds TD, Mohan V, Roy M, Manghat N, Adamali H, Gunawardena H.

Eur J Rheumatol. 2017 Dec;4(4):278-280. doi: 10.5152/eurjrheum.2017.17036. Epub 2017 Oct 25.

10.

Lesson of the month 2: Dry skin, yellow nails and breathlessness.

Fallon J, Majeed S, Adamali H, Gunawardena H.

Clin Med (Lond). 2017 Jul;17(4):371-372. doi: 10.7861/clinmedicine.17-4-371.

11.

Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis.

Sharp C, Lamb H, Jordan N, Edwards A, Gunary R, Meek P, Millar AB, Kendall C, Adamali H.

BMJ Support Palliat Care. 2018 Sep;8(3):340-346. doi: 10.1136/bmjspcare-2017-001330. Epub 2017 Jun 30.

PMID:
28667087
12.

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.

Visca D, Tsipouri V, Mori L, Firouzi A, Fleming S, Farquhar M, Leung E, Maher TM, Cullinan P, Hopkinson N, Wells AU, Banya W, Whitty JA, Adamali H, Spencer LG, Sestini P, Renzoni EA.

Trials. 2017 Apr 28;18(1):201. doi: 10.1186/s13063-017-1912-9.

13.

A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis.

Sharp C, Adamali HI, Millar AB.

ERJ Open Res. 2017 Mar 14;3(1). pii: 00096-2016. doi: 10.1183/23120541.00096-2016. eCollection 2017 Jan.

14.

Developments in Cryobiopsy for Interstitial Lung Disease May Be Cost Saving.

Sharp C, Adamali H, Medford A.

Chest. 2017 Feb;151(2):512-513. doi: 10.1016/j.chest.2016.10.060. No abstract available.

PMID:
28183489
15.

Idiopathic pulmonary fibrosis: current and future directions.

Soo E, Adamali H, Edey AJ.

Clin Radiol. 2017 May;72(5):343-355. doi: 10.1016/j.crad.2016.12.014. Epub 2017 Jan 21. Review.

PMID:
28118995
16.

Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease-a systematic review and cost analysis.

Sharp C, McCabe M, Adamali H, Medford AR.

QJM. 2017 Apr 1;110(4):207-214. doi: 10.1093/qjmed/hcw142. Review.

PMID:
27521581
17.

Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study.

Sharp C, McCabe M, Hussain MJ, Dodd JW, Lamb H, Adamali H, Millar AB, Smith D.

QJM. 2017 Jan;110(1):17-22. doi: 10.1093/qjmed/hcw105. Epub 2016 Jul 10.

PMID:
27402855
18.

Ambulatory and short-burst oxygen for interstitial lung disease.

Sharp C, Adamali H, Millar AB.

Cochrane Database Syst Rev. 2016 Jul 6;7:CD011716. doi: 10.1002/14651858.CD011716.pub2. Review.

PMID:
27383922
19.

Response.

Baggott C, Sharp C, Bhatt N, Plummeridge M, Adamali H.

Clin Med (Lond). 2016 Jun;16(3):302. doi: 10.7861/clinmedicine.16-3-302a. No abstract available.

20.

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, Wells AU, Maher TM.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):989-997.

21.

Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.

Sharp C, McCabe M, Dodds N, Edey A, Mayers L, Adamali H, Millar AB, Gunawardena H.

Rheumatology (Oxford). 2016 Jul;55(7):1318-24. doi: 10.1093/rheumatology/kew195. Epub 2016 Apr 8.

PMID:
27060110
22.

Response.

Baggott C, Sharp C, Bhatt N, Plummeridge M, Adamali H.

Clin Med (Lond). 2016 Apr;16(2):207. doi: 10.7861/clinmedicine.16-2-207a. No abstract available.

23.

Response.

Baggott C, Sharp C, Bhatt N, Plummeridge M, Adamali H.

Clin Med (Lond). 2016 Feb;16(1):96. doi: 10.7861/clinmedicine.16-1-96. No abstract available.

24.

Lesson of the month 1: A cough that doesn't fit the mould.

Baggott C, Sharp C, Bhatt N, Plummeridge M, Adamali H.

Clin Med (Lond). 2015 Oct;15(5):492-4. doi: 10.7861/clinmedicine.15-5-492.

25.

The role of biologics in treatment of connective tissue disease-associated interstitial lung disease.

Sharp C, Dodds N, Mayers L, Millar AB, Gunawardena H, Adamali H.

QJM. 2015 Sep;108(9):683-8. doi: 10.1093/qjmed/hcv007. Epub 2015 Jan 21. Review.

PMID:
25614613
26.

A national house-staff audit of medical prophylaxis in medical patients for the PREVENTion of Venous ThromboEmbolism (PREVENT-VTE).

Adamali H, Suliman AM, Zaid H, O'Donoghue E, Burke A, Suliman AW, Salem M, O'Toole A, Yearoo AI, Javid S, Ullah I, Bolger K, Dunican E, McCullagh B, Curtin D, Lonergan MT, Dillon L, Murphy AW, Gaine S; PREVENT VTE Investigators.

Ir Med J. 2013 Nov-Dec;106(10):302-5.

PMID:
24579409
27.

Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register.

Mason RH, Foley NM, Branley HM, Adamali HI, Hetzel M, Maher TM, Suntharalingam J.

Thorax. 2014 Aug;69(8):766-7. doi: 10.1136/thoraxjnl-2013-204313. Epub 2014 Jan 30.

PMID:
24482091
28.

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.

Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA.

Thorax. 2013 May;68(5):436-41. doi: 10.1136/thoraxjnl-2012-201786. Epub 2013 Jan 15.

PMID:
23321605
29.

Current and novel drug therapies for idiopathic pulmonary fibrosis.

Adamali HI, Maher TM.

Drug Des Devel Ther. 2012;6:261-72. doi: 10.2147/DDDT.S29928. Epub 2012 Sep 26. Review.

30.

Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.

Adamali H, Armstrong ME, McLaughlin AM, Cooke G, McKone E, Costello CM, Gallagher CG, Leng L, Baugh JA, Fingerle-Rowson G, Bucala RJ, McLoughlin P, Donnelly SC.

Am J Respir Crit Care Med. 2012 Jul 15;186(2):162-9. doi: 10.1164/rccm.201110-1864OC. Epub 2012 May 16.

31.

International collaboration: a retrospective study examining the survival of Irish citizens following lung transplantation in both the UK and Ireland.

Adamali HI, Judge EP, Healy D, Nolke L, Redmond KC, Bartosik W, McCarthy J, Egan JJ.

BMJ Open. 2012 Mar 28;2(2):e000605. doi: 10.1136/bmjopen-2011-000605. Print 2012.

32.

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Judge EP, Fabre A, Adamali HI, Egan JJ.

Eur Respir J. 2012 Jul;40(1):93-100. doi: 10.1183/09031936.00115511. Epub 2011 Dec 1.

33.

Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study.

Egan JJ, Adamali HI, Lok SS, Stewart JP, Woodcock AA.

Pulm Med. 2011;2011:240805. doi: 10.1155/2011/240805. Epub 2011 Apr 7.

34.

Medical treatment of pulmonary arterial hypertension.

Adamali H, Gaine SP, Rubin LJ.

Semin Respir Crit Care Med. 2009 Aug;30(4):484-92. doi: 10.1055/s-0029-1233317. Epub 2009 Jul 24. Review.

PMID:
19634087
35.

The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.

Adamali HI, Gibney J, O'Shea D, Casey M, McKenna TJ.

Ir J Med Sci. 2007 Sep;176(3):199-203. Epub 2007 Jul 14.

PMID:
17632747
36.
37.

Expression and regulation of H+K+ATPase in lysosomes of epithelial cells of the adult rat epididymis.

Andonian S, Adamali H, Hermo L.

Mol Reprod Dev. 2001 Apr;58(4):398-410.

PMID:
11241776
38.

Immunolocalization of CA II and H+ V-ATPase in epithelial cells of the mouse and rat epididymis.

Hermo L, Adamali HI, Andonian S.

J Androl. 2000 May-Jun;21(3):376-91.

39.
40.

I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.

Adamali HI, Somani IH, Huang JQ, Mahuran D, Gravel RA, Trasler JM, Hermo L.

J Androl. 1999 Nov-Dec;20(6):779-802.

41.

Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.

Trasler J, Saberi F, Somani IH, Adamali HI, Huang JQ, Fortunato SR, Ritter G, Gu M, Aebersold R, Gravel RA, Hermo L.

Endocrinology. 1998 Jul;139(7):3280-8.

PMID:
9645704
42.

beta-Hexosaminidase immunolocalization and alpha- and beta-subunit gene expression in the rat testis and epididymis.

Hermo L, Adamali HI, Mahuran D, Gravel RA, Trasler JM.

Mol Reprod Dev. 1997 Mar;46(3):227-42.

PMID:
9041125

Supplemental Content

Loading ...
Support Center